There is a strong association between circulating concentrations of CXCL13 and both clinical manifestations and disease progression of IPF [13], whereas immune settings of B cells and Tfh cells in the pathogenesis of IPF are still ill-defined. Here, CXCL13 is linked to idiopathic pulmonary fibrosis.